Biotech · Private company
Baudax Bio
Track this companyFree. Adds Baudax Bio to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- N1539Phase 3 · Pain, Post-operativeClinicalTrials.gov · fetched Nov 12, 2026
- N1539Phase 3 · Pain, PostoperativeClinicalTrials.gov · fetched Nov 12, 2026
- BX1000Phase 2 · Neuromuscular BlockadeClinicalTrials.gov · fetched Nov 12, 2026
- DEX-INPhase 2 · PainClinicalTrials.gov · fetched Nov 12, 2026
- FentanylPhase 2 · PainClinicalTrials.gov · fetched Nov 12, 2026
- Rocuronium BromidePhase 2 · Neuromuscular BlockadeClinicalTrials.gov · fetched Nov 12, 2026
- N1539Post Operative PainClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Evaluation of Intubation Conditions Following BX1000 or Rocuronium in Subjects Undergoing SurgeryPHASE2 · COMPLETED · started Oct 25, 2022ClinicalTrials.gov NCT05687253 · fetched Nov 12, 2026
- Safety and Pharmacokinetics of N1539 in Children 2 to <17 Years of Age Following SurgeryPHASE4 · TERMINATED · started Feb 24, 2022ClinicalTrials.gov NCT05315479 · fetched Nov 12, 2026
- Evaluation of Preoperative N1539 in Total Knee ArthroplastyPHASE3 · COMPLETED · started Feb 19, 2018ClinicalTrials.gov NCT03434275 · fetched Nov 12, 2026
- Evaluation of DEX-IN During Outpatient ProceduresPHASE2 · COMPLETED · started Nov 15, 2017ClinicalTrials.gov NCT03348423 · fetched Nov 12, 2026
- Evaluation of Preoperative N1539 in Colorectal SurgeryPHASE3 · COMPLETED · started Oct 24, 2017ClinicalTrials.gov NCT03323385 · fetched Nov 12, 2026
- Evaluation of N1539 Following Major SurgeryPHASE3 · COMPLETED · started Mar 1, 2016ClinicalTrials.gov NCT02720692 · fetched Nov 12, 2026